Martingale Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Martingale Asset Management's AMRX Position: Q3 2026 in Review
Martingale Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 21% in Q3 2026, selling an estimated $1.08M and leaving 222,931 shares worth $4.49M. The position accounts for 0.11% of the portfolio, ranked #194.
Martingale Asset Management first reported a position in AMRX in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.9M in Q2 2026. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Martingale Asset Management held 222,931 shares of Amneal Pharmaceuticals worth $4.49M as of Q3 2026.
- Martingale Asset Management sold 60,102 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.08M.
- Amneal Pharmaceuticals made up 0.11% of Martingale Asset Management's portfolio in Q3 2026, its #194 holding.
- Martingale Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- Martingale Asset Management's Amneal Pharmaceuticals position peaked at $4.9M in Q2 2026.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.